Curran Simpson is President and Chief Executive Officer of REGENXBIO Inc. (RGNX). The company reported total compensation of $4,200,712 for fiscal year 2025.
| Salary | $665,510 |
|---|---|
| Bonus | $0 |
| Stock awards | $777,448 |
| Option awards | $2,350,302 |
| Non-equity incentive plan | $387,327 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $20,125 |
| Total | $4,200,712 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure REGENXBIO Inc. filed April 14, 2026, accession 0001193125-26-155058.
| Fiscal year | Role | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | President and Chief Executive Officer | $665,510 | $0 | $777,448 | $2,350,302 | $387,327 | $0 | $20,125 | $4,200,712 |
| FY2024 | President and Chief Executive Officer | $571,723 | — | $1,330,383 | $2,572,911 | $289,689 | — | $19,838 | $4,784,543 |
Totals as disclosed in each year's own compensation disclosure for REGENXBIO Inc..
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Curran Simpson this page | President and Chief Executive Officer | $4,200,712 |
| Patrick Christmas | EVP, Chief Strategy and Legal Officer | $2,041,511 |
| Stephen Pakola | EVP, Chief Medical Officer | $1,799,546 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full REGENXBIO Inc. compensation brief.
Curran Simpson's compensation sits inside REGENXBIO Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.